CXCL8 and neoplasm: Post-FMT analyses revealed the increased activation of CD8+ T-cells, a key component of antitumor immunity, alongside a reduction in interleukin-8 expression from myeloid cells, which is often associated with an immunosuppressive tumor microenvironment.